Study of an experimental drug for advanced solid tumors
Part of Cancer, Digestive system, Lungs & breathing clinical trials.
This trial tests an experimental drug called FXB0871 in people with advanced solid tumors that have stopped responding to standard treatments or for whom no standard treatment exists. The goal is to see if the drug is safe and effective, and patients who enroll will receive close monitoring throughout the study.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older and have a type of advanced solid tumor that has progressed on or is not suitable for standard therapy.
- You need to be generally well enough to perform daily activities (performance status 0 or 1).
- You must have at least one measurable tumor.
- You need to have a tumor tissue sample available from a previous biopsy or be willing to have a fresh one.
- Your heart, liver, kidney, and blood counts must be within acceptable ranges.
- You must not have had certain cancer treatments within the past 4 weeks, and you must not have been previously treated with drugs like IL-2, IL-15, or IL-7.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an experimental drug called FXS887 for people with advanced solid tumors that have stopped responding to standard treatments. The goal is to see if FXS887 can help shrink or control the tumor.
This trial tests a new drug called FG-B901, either alone or with chemotherapy, for people with advanced solid tumors that haven't responded to standard treatment. The goal is to see if the drug can shrink tumors or slow their growth.
This Phase 1 trial tests HS-20089 in people with advanced solid cancers that have limited standard treatment options. It focuses on safety and early signs of whether the drug can shrink tumors or control them.
This trial tests an experimental drug called BL-M08D1 for people with solid tumors that have spread or cannot be removed by surgery and have stopped responding to standard treatments. The goal is to see if the drug is safe and effective.
This trial tests a new drug that may help people with advanced solid tumors, including liver, stomach, and brain cancers. It is for patients whose cancer has not responded to standard treatments or who cannot have them. The study aims to find the right dose and check safety and effectiveness.
This trial tests an experimental drug for people with advanced solid tumors, including small cell lung cancer, that have stopped responding to standard treatments. The goal is to find out if the drug is safe and effective.
Hear when a new Non Small Cell Lung Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.